1H-pyrido[2,3]furo[2,4-b]pyrimidine-2,4-dione结构式
|
常用名 | 1H-pyrido[2,3]furo[2,4-b]pyrimidine-2,4-dione | 英文名 | 1H-pyrido[2,3]furo[2,4-b]pyrimidine-2,4-dione |
---|---|---|---|---|
CAS号 | 1235181-59-5 | 分子量 | 203.15400 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C9H5N3O3 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | 1H-pyrido[2,3]furo[2,4-b]pyrimidine-2,4-dione |
---|---|
英文别名 | 更多 |
分子式 | C9H5N3O3 |
---|---|
分子量 | 203.15400 |
精确质量 | 203.03300 |
PSA | 92.01000 |
LogP | 0.76990 |
~40% 1H-pyrido[2,3]f... 1235181-59-5 |
文献:KARUS THERAPEUTICS LIMITED; SHUTTLEWORTH, Stephen Joseph; CECIL, Alexander Richard Liam; HILL, Thomas James; SILVA, Franck Alexandre Patent: WO2011/21038 A1, 2011 ; Location in patent: Page/Page column 19; 24-25 ; WO 2011/021038 A1 |
~% 1H-pyrido[2,3]f... 1235181-59-5 |
文献:KARUS THERAPEUTICS LIMITED; SHUTTLEWORTH, Stephen Joseph; CECIL, Alexander Richard Liam; HILL, Thomas James; SILVA, Franck Alexandre Patent: WO2011/21038 A1, 2011 ; WO 2011/021038 A1 |
1H-pyrido[3',2':4,5]furo[3,2-d]pyrimidine-2,4-dione |
pyrimidino[4',5'-5,4]furano[2,3-b]pyridine-2,4-diol |
SS-5051 |
QC-5326 |
8-oxa-3,5,10-triazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,5,9,11-hexaene-4,6-diol |